Archivio istituzionale della ricerca dell'Università degli Studi di Palermo

CICERO, Giuseppe
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 11.771
EU - Europa 5.255
AS - Asia 4.474
SA - Sud America 697
Continente sconosciuto - Info sul continente non disponibili 585
AF - Africa 115
OC - Oceania 28
Totale 22.925
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 11.546
SG - Singapore 1.505
RU - Federazione Russa 1.313
CN - Cina 1.231
IT - Italia 1.050
FI - Finlandia 689
BR - Brasile 541
DE - Germania 536
HK - Hong Kong 412
VN - Vietnam 404
GB - Regno Unito 301
UA - Ucraina 268
PL - Polonia 241
IE - Irlanda 218
FR - Francia 196
JP - Giappone 155
BD - Bangladesh 135
SE - Svezia 125
CA - Canada 118
KR - Corea 118
IN - India 114
IQ - Iraq 65
TR - Turchia 65
AR - Argentina 62
RO - Romania 54
BE - Belgio 53
NL - Olanda 50
ES - Italia 42
MX - Messico 37
ZA - Sudafrica 33
MY - Malesia 32
AT - Austria 31
UZ - Uzbekistan 28
PH - Filippine 25
AU - Australia 24
IR - Iran 22
VE - Venezuela 20
CI - Costa d'Avorio 18
EC - Ecuador 18
SA - Arabia Saudita 18
CO - Colombia 17
CR - Costa Rica 17
ID - Indonesia 17
CL - Cile 16
MA - Marocco 15
IL - Israele 13
PY - Paraguay 13
CZ - Repubblica Ceca 12
NP - Nepal 12
PK - Pakistan 12
JO - Giordania 11
LT - Lituania 11
AE - Emirati Arabi Uniti 10
HN - Honduras 10
JM - Giamaica 10
TN - Tunisia 9
TW - Taiwan 9
CH - Svizzera 8
KZ - Kazakistan 8
DZ - Algeria 7
EG - Egitto 7
KE - Kenya 7
SI - Slovenia 7
DK - Danimarca 6
GR - Grecia 6
LB - Libano 6
PT - Portogallo 6
SY - Repubblica araba siriana 6
AZ - Azerbaigian 5
DO - Repubblica Dominicana 5
KG - Kirghizistan 5
KW - Kuwait 5
NI - Nicaragua 5
NO - Norvegia 5
PA - Panama 5
SV - El Salvador 5
UY - Uruguay 5
BG - Bulgaria 4
BY - Bielorussia 4
EU - Europa 4
HU - Ungheria 4
NZ - Nuova Zelanda 4
OM - Oman 4
SD - Sudan 4
AM - Armenia 3
NG - Nigeria 3
PE - Perù 3
PR - Porto Rico 3
TT - Trinidad e Tobago 3
BA - Bosnia-Erzegovina 2
BH - Bahrain 2
CM - Camerun 2
EE - Estonia 2
ET - Etiopia 2
GA - Gabon 2
GT - Guatemala 2
HR - Croazia 2
LV - Lettonia 2
MM - Myanmar 2
PS - Palestinian Territory 2
Totale 22.311
Salva come PNG Salva come JPEG
Città #
Ashburn 1.470
Fairfield 1.372
Singapore 1.002
Woodbridge 745
Chandler 686
San Jose 622
Houston 567
Seattle 561
Wilmington 552
Ann Arbor 524
Cambridge 479
Hong Kong 393
Palermo 268
Moscow 240
Council Bluffs 213
Dublin 212
Zgierz 209
Beijing 180
Santa Clara 173
Medford 168
Los Angeles 154
New York 151
Tokyo 147
Jacksonville 128
Ho Chi Minh City 124
Hefei 119
Altamura 116
Des Moines 114
Boardman 111
Nanjing 108
Frankfurt am Main 107
Dallas 102
Princeton 102
Hanoi 99
Helsinki 97
Lauterbourg 97
The Dalles 93
Lawrence 89
San Diego 78
Dearborn 69
Buffalo 54
Changsha 54
Milan 52
Brussels 51
São Paulo 51
London 49
Shenyang 49
Tulsa 49
Phoenix 48
Chicago 42
Orem 41
Rome 41
Ludwigshafen am Rhein 38
Nanchang 35
Nuremberg 34
Jinan 33
Hebei 32
Tianjin 32
Bremen 31
Seoul 31
Toronto 30
Zhengzhou 30
Kumar 29
Jiaxing 28
Denver 27
Amsterdam 26
Guangzhou 26
Montreal 26
Panama City 26
Chennai 25
Izmir 25
Atlanta 24
Da Nang 24
Baghdad 23
Munich 23
Columbus 22
Redwood City 22
Brooklyn 21
Ningbo 21
Falls Church 20
Stockholm 20
Berlin 19
Saint Petersburg 19
Tashkent 19
Haiphong 18
Seongnam 18
Shanghai 18
Warsaw 18
Abidjan 17
Poplar 17
Boydton 16
Johannesburg 16
Rio de Janeiro 16
Venice 15
Verona 15
Auburn Hills 14
Hangzhou 14
Pune 14
Vienna 14
San Paolo di Civitate 13
Totale 14.516
Salva come PNG Salva come JPEG
Nome #
Clinical and biochemical markers of visceral adipose tissue activity: Body mass index, visceral adiposity index, leptin, adiponectin, and matrix metalloproteinase-3. Correlation with Gleason patterns 4 and 5 at prostate biopsy 350
PD-L1 expression as predictive biomarker in patients with NSCLC: A pooled analysis 349
Detection and quantification of mammaglobin in the blood of breast cancer patients: can it be useful as a potential clinical marker? Preliminary results of a GOIM (Gruppo Oncologico dell'Italia Meridionale) prospective study. 342
Psychological distress and quality of life in ostomy patients with colorectal cancer: A systematic review of the literature 318
Stabilizing versus destabilizing the microtubules: A double-edge sword for an effective cancer treatment option? 317
Analysis of Germline Gene Copy Number Variants of Patients with Sporadic Pancreatic Adenocarcinoma Reveals Specific Variations 314
Significance of P16INK4A hypermethylation gene in primary head/neck and colorectal tumors: it is a specific tissue event? Results of a 3-year GOIM (Gruppo Oncologico dell'Italia Meridionale) prospective study 305
Gastrointestinal stromal tumors (GISTs): focus on histopathological diagnosis and biomolecular features 303
Characterization of human γδ T lymphocytes infiltrating primary malignant melanomas 303
Co-expression of CD133+/CD44+in human colon cancer and liver metastasis 297
Relationship between anxiety level and radiological investigation. Comparison among different diagnostic imaging exams in a prospective single-center study 297
Distinctive features of tumor-infiltrating gd T lymphocytes in human colorectal cancer 293
A headlight on liquid biopsies: a challenging tool for breast cancer management 290
Cabazitaxel in Metastatic Castration-Resistant Prostate Cancer Patients Progressing after Docetaxel: A Prospective Single-Center Study 287
What are the Cancer Risks in BRCA Carriers Apart from Those Regarding the Breast and the Ovary? 284
I tumori della mammella e/o dell’ovaio di tipo eredofamiliare: strategie di prevenzione nelle donne ad alto rischio 279
Effects of anti-miR-182 on TSP-1 expression in human colon cancer cells: there is a sense in antisense? 278
A phase II study of pegylated liposomal doxorubicin oxaliplatin and cyclophosphamide as second-line treatment in relapsed ovarian carcinoma 277
Are erlotinib and gefitinib interchangeable, opposite or complementary for non-small cell lung cancer treatment? Biological, pharmacological and clinical aspects 277
Triple negative breast cancer: Shedding light onto the role of pi3k/akt/mtor pathway 275
Whatsapp messenger as a tool for the multidisciplinary management in everyday clinical practice 271
Risk Perception and Psychological Distress in Genetic Counselling for Hereditary Breast and/or Ovarian Cancer 270
The use of zoledronic acid in patients with bone metastases from prostate carcinoma: effect on analgesic response and bone metabolism biomarkers 268
How Much of Familial Breast Cancer Risk is Currently Explained by the Known Genes? 267
HSP10,HSP70 AND HSP90 IMMUNOHISTOCHEMICAL LEVELS CHANGE IN ULCERATIVE COLITIS AFTER THERAPY 265
Specific TP53 and/or Ki-ras mutations as independent predictors of clinical outcome in sporadic colorectal adenocarcinomas: results of a 5-year Gruppo Oncologico dell'Italia Meridionale (GOIM) prospective study. 263
Targeted Therapies in Hepatocellular Carcinoma 263
New findings on primary and acquired resistance to anti-EGFR therapy in metastatic colorectal cancer: Do all roads lead to RAS? 261
The role of microRNAs in cancer: diagnostic and prognostic biomarkers and targets of therapies 259
Clinical efficacy of nab-paclitaxel in patients with metastatic pancreatic cancer 257
Effects of PPARγ agonists on the expression of leptin and vascular endothelial growth factor in breast cancer cells. 257
A case of guillain-barre syndrome in a patient with non small cell lung cancer treated with chemotherapy 255
Gemcitabine (GEM) plus oxaliplatin, folinic acid, and 5-fluorouracil (FOLFOX-4) in patients with advanced gastric cancer. 252
Monoclonal antibodies in gastrointestinal cancers 252
Circulating exosomal Hsp60 as a new marker of colon cancer. 251
HIF-1 is involved in the negative regulation of AURKA expression in breast cancer cell lines under hypoxic conditions 250
Farletuzumab for NSCLC: Exploiting a well-known metabolic pathway for a new therapeutic strategy 248
Cetuximab rechallenge in metastatic colorectal cancer patients: how to come away from acquired resistance? 243
MicroRNAs in colorectal cancer stem cells: new regulators of cancer stemness? 241
Hypoxia and Human Genome Stability: Downregulation of BRCA2 Expression in Breast Cancer Cell Lines 241
MicroRNAs in Colorectal Cancer Drug Resistance: Shooters become Targets 237
Combining conventional chemotherapy and γδ T cell-based immunotherapy to target cancer-initiating cells 236
Characterization of γδ T cells in intestinal mucosa from patients with early onset or long standing inflammatory bowel disease and their correlation with clinical status 235
Nab-paclitaxel in pretreated metastatic breast cancer: evaluation of activity, safety, and quality of life 229
Studio di fase II con Taxotere + Doxorubicina liposomiale + Trastuzumab nel trattamento del carcinoma mammario metastatico c-erb-B2 positivo 223
WHATSAPP MESSENGER AS A REAL-TIME TOOL FOR A LONG-DISTANCE ACTIVITY OF A MULTIDISCIPLINARY 223
The patient-physician relationship in the face of oncological disease: A review of literature on the emotional and psychological reactions of patients and physician 222
Intravesical chemotherapy for intermediate risk non-muscle invasive bladder cancer recurring after a first cycle of intravesical adjuvant therapy 220
Primary Non-Hodgkin’s lymphoma of the parotid gland 218
Impact of microRNAs in Resistance to Chemotherapy and Novel Targeted Agents in Non-Small Cell Lung Cancer 216
Targeting apoptosis in solid tumors: the role of bortezomib from preclinical to clinical evidence. 215
Does the Compliance to Intravesical BCG Differ between Common Clinical Practice and International Multicentric Trials? 215
Gemcitabine and oxaliplatin combination chemotherapy in advanced biliary tract cancers 210
Well-being among Italian medical oncologists: An exploratory study 210
In vivo manipulation of Vgamma9Vdelta2 T cells with zoledronate and low-dose interleukin-2 for immunotherapy of advanced breast cancer patients. 208
The Risk of Toxicities from Trastuzumab, Alone or in Combination, in an Elderly Breast Cancer Population 208
Vg9Vd2 T cells as a promising innovative tool for immunotherapy of hematologic malignancies 207
Aminobisphosphonates as New Weapons for gammaDelta T Cell-Based Immunotherapy of Cancer 206
Impact of combination chemotherapy on toxicity in ovarian cancer: Systematic revision of literature and meta-analysis 206
Progression-free survival as a surrogate endpoint of overall survival in patients with metastatic colorectal cancer 206
Bortezomib: a new pro-apoptotic agent in cancer treatment. 204
Immunotherapy for recurrent ovarian cancer: a further piece of the puzzle or a striking strategy? 200
Evaluation of predictive factors for i-CLARAS (intraoperative complications in laparoscopic renal and adrenal surgery): a multicentre international retrospective cohort study 198
Targeting human {gamma}delta} T cells with zoledronate and interleukin-2 for immunotherapy of hormone-refractory prostate cancer. 194
The molecular changes driving the carcinogenesis in Barrett's esophagus: Which came first, the chicken or the egg? 193
Zoledronic acid induces a significant decrease of circulating endothelial cells and circulating endothelial precursor cells in the early prostate cancer neoadjuvant setting 193
The Role of Couples' Attachment Styles in Patients' Adjustment to Cancer 193
The clinical efficacy of enzalutamide in metastatic prostate cancer: Prospective single-center study 193
Docetaxel plus prednisone in patients with metastatic hormone-refractory prostate cancer: an italian clinical axperience 191
Does Exist A Correlation Between BMI and Gleason Patterns 4 and 5 At Prostate Biopsy? 189
Raltitrexed plus levofolinic acid and bolus/continuous infusion 5- Fluorouracil on a biweekly schedule for elderly patients with advanced colorectal carcinomas 188
Studio pilota sul valore predittivo dei livelli plasmatici di 9 fattori angiogenetici nella selezione di pazienti candidati alla biopsia prostatica 186
Geldanamycin and its derivatives as Hsp90 inhibitors 184
Chemotherapy Sensitizes Colon Cancer Initiating Cells to Vγ9Vδ2 T Cell-Mediated Cytotoxicity 183
Unusual case of dorsal vertebral metastases from a male breast cancer 183
Heterogeneity and prognostic influence of tumor- infiltrating γδ T lymphocytes in colon cancer patients 182
Cardiotossicità e Cardioprotezione. 181
The gene expression profile of cumulus cells reveals altered pathways in patients with endometriosis 178
Studio di fase II con Gemcitabine + Oxaliplatino in combinazione nel trattamento delle neoplasie delle vie biliari, pancreas e colecisti in fase metastatica. 177
Corrigendum: Cetuximab rechallenge in metastatic colorectal cancer patients: How to come away from acquired resistance? 177
Efficacy and Safety of the Oral Multikinase Regorafenib in Metastatic Colorectal Cancer 175
Role of densitometric criteria in evaluation of effectiveness of antiangiogenic therapies in metastatic colorectal cancer: An Italian clinical experience 173
Correlation between leptin plasmatic levels in non-obese patients and detection rate at prostate biopsy”- Poster P147 164
Nivolumab in metastatic melanoma: good efficacy and tolerability in elderly patients 161
The Clinical Efficacy of Radium-223 for Bone Metastasis in Patients with Castration-Resistant Prostate Cancer: An Italian Clinical Experience 159
Prognostic and predictive biomarkers for targeted therapy in NSCLC: For whom the bell tolls? 158
Emergenze metaboliche 153
Tas-102 in metastatic colorectal cancer (MCRC): Efficacy, tolerability, and quality of life in heavily pretreated elderly patients: A real-life study 153
Leptin plasma levels in patients undergoing prostate biopsy. a preliminary study in 50 patients 148
Germline copy number variation in the YTHDC2 gene: does it have a role in finding a novel potential molecular target involved in pancreatic adenocarcinoma susceptibility? 147
La terapia adiuvante nel carcinoma del colon: un update della lettaratura 143
Ramucirumab and its use in gastric cancer treatment 142
Evaluation of anxiety level in patients wating to undergo to diagnostic radiological exams 141
Vinflunine in Metastatic Urothelial Carcinoma of the Bladder in Progression after a Platinum-Containing Regimen 141
CORRELATION BETWEEN FIBRONECTIN GENE EXPRESSION AND LOCAL TOXICITY INDUCED BY ADJUVANT INTRAVESICAL THERAPY 136
Use of Eribulin mesylate as second-line therapy in elderly patients with HER/2 negative metastatic breast cancer (MBC): Efficacy, tolerability and Quality of Life 127
Avelumab in First Line Maintenance in Advanced Urothelial Carcinoma (aUC) in Elderly Patients: Efficacy, Tolerability, and Quality of Life in Real Life Setting 123
Treatment with abiraterone in metastatic castration-resistant prostate cancer patients progressing after docetaxel: A retrospective study 116
NEPA (netupitant/palonosetron) for the antiemetic prophylaxis of nausea and vomiting induced by chemotherapy (CINV) with Folfirinox and Folfoxiri even during the COVID-19 pandemic: A real-life study 115
Terapia medica e supporto psicologico in un gruppo di pazienti affette da carcinoma mammario 109
Totale 22.170
Salva come PNG Salva come JPEG
Categoria #
all - tutte 74.850
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 74.850
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.462 0 308 65 96 78 73 91 107 157 130 127 230
2022/20231.912 196 381 38 235 217 260 84 154 189 11 99 48
2023/2024885 32 107 60 67 57 162 78 111 7 28 40 136
2024/20252.267 49 175 233 171 103 87 151 185 133 253 282 445
2025/20267.704 612 242 405 653 715 1.164 1.011 825 525 881 316 355
2026/2027434 369 65 0 0 0 0 0 0 0 0 0 0
Totale 22.925